Zydus Lifesciences Ltd

ZYDUSLIFE13 Nov 2024
Pharmaceuticals
+14.20 (+1.50%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
Pharmaceuticals
ZYDUSLIFE13 Nov 2024
+14.20 (+1.50%)
1D
1M
6M
1Y
5Y
All

Zydus Lifesciences Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
52.36%
Upper Circuit
Lower Circuit
P/E TTM
21.89
P/B Ratio
6.08
Traded Value(Cr)
2.00
EPS TTM
43.41
Book value
Dividend
0.32%

Invest in Zydus Lifesciences Ltd at ZERO Brokerage for 30 days

Reports

How to buy Zydus Lifesciences Ltd shares on nse?

To buy Zydus Lifesciences Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Zydus Lifesciences Ltd share price today?

The Zydus Lifesciences Ltd shares price on nse is Rs.963.95 today.

What is the market cap of Zydus Lifesciences Ltd shares on NSE ?

The company has a market capitalization of Rs.95567.07Cr

What is the PE & PB ratio of Zydus Lifesciences Ltd shares ?

PE is 21.89 and PB is 6.08

What is the 52 Week High and Low of Zydus Lifesciences Ltd shares?

Zydus Lifesciences Ltd stock price high: Rs.1324.3 Zydus Lifesciences Ltd stock price low: Rs.616.05

What is Zydus Lifesciences' stock forecast?

With a new 52-week high, the Zydus Lifesciences stock is expected to outperform in the near term. The average target as of May 11, 2023, is Rs. 521 – a 1.41% increase from the current price of Rs. 513.75.

What is Zydus Lifesciences stock's highest price ever?

The highest price ever for Zydus Lifesciences was Rs. 650.50 on 4th June 2021. 

What is the Zydus Lifesciences stock price target for 2024?

Zydus Lifesciences continues to build a robust product pipeline in innovative, branded generics, as well as genetics categories. Further, the operational efficiency is expected to drive better-than-industry growth in the DF segment. However, analysts at Motilal Oswal have reiterated a ‘neutral’ outlook on the stock, given limited upside from the current levels.

Does Zydus Lifesciences have a solid foundation?

Zydus Lifesciences has a solid foundation that has triggered its recent bullish run. It has a strong presence in the pharmaceutical industry and has been operating for several decades in the development, manufacturing, and marketing of a wide range of healthcare products, including pharmaceuticals, diagnostics, herbal products, and wellness products. With a recent FDA clearance on a pulmonary drug and better-than-expected Q3 profits, Zydus has shown stable and reliable growth. 

What is the Zydus Lifesciences stock dividend payout date?

Zydus Lifesciences is expected to pay its stock dividend in July. The company consistently paid dividends in July for the past two years.

What is the most recent Zydus Lifesciences stock news?

Zydus received the USFDA nod to manufacture and market drugs for osteoporosis, ulcer, blood pressure, heart disease, and pulmonary infections, and general anti-inflammatories. Furthermore, it is looking to sell its clinical research business for close to USD 200 million.